Insmed
INSM
#730
Rank
HK$261.38 B
Marketcap
HK$1,226
Share price
-0.60%
Change (1 day)
101.88%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: HK$261.38 Billion

As of February 2026 Insmed has a market cap of HK$261.38 Billion. This makes Insmed the world's 730th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$261.38 B-11.45%
2025HK$295.17 B205.3%
2024HK$96.68 B179.22%
2023HK$34.62 B63.72%
2022HK$21.14 B-15.88%
2021HK$25.14 B-4.36%
2020HK$26.28 B57.62%
2019HK$16.67 B109.99%
2018HK$7.94 B-57.43%
2017HK$18.65 B193.91%
2016HK$6.34 B-27%
2015HK$8.69 B45.5%
2014HK$5.97 B15.84%
2013HK$5.15 B215.97%
2012HK$1.63 B177.56%
2011HK$0.58 B-23.45%
2010HK$0.76 B-1.15%
2009HK$0.77 B75.93%
2008HK$0.44 B-43.65%
2007HK$0.78 B13.07%
2006HK$0.69 B-31.75%
2005HK$1.01 B32.45%
2004HK$0.76 B-13.2%
2003HK$0.88 B660.65%
2002HK$0.11 B-88.15%
2001HK$0.98 B10.54%
2000HK$0.88 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Insmed was reported to be:

HK$261.38 Billion
by Nasdaq info icon info icon
HK$261.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
HK$2.228 T 752.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
HK$1.376 T 426.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$941.25 B 260.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$16.65 B-93.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
HK$5.88 B-97.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
HK$13.51 B-94.83%๐Ÿ‡บ๐Ÿ‡ธ USA